Piramal Pharma Limited schließt die Übernahme einer Mehrheitsbeteiligung an Yapan Bio Private Limited ab

Positive

AI Analysis

Summary

Piramal Pharma completed its acquisition of a majority stake in Yapan Bio Private Limited, a contract manufacturing organization specializing in process development, characterization, and GMP-compliant manufacturing services for Phase I and II clinical trials of vaccines and biologics.

Outcome Details

Piramal Pharma completed acquisition of majority stake in Yapan Bio Private Limited

Importance:6/10

Sentiment:

0.60

acquisitionmajority stakevaccine manufacturingbiologicsGMP manufacturingclinical trial services

Read the original article

Published by PR Newswire Biotech on August 19, 2026 10:00 PM

Read Original